Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to $1.7 million.

  • Nexgel's Cost of Revenue fell 526.61% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 3255.23%. This contributed to the annual value of $5.9 million for FY2024, which is 5989.23% up from last year.
  • Nexgel's Cost of Revenue amounted to $1.7 million in Q3 2025, which was down 526.61% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, Nexgel's Cost of Revenue peaked at $2.0 million during Q4 2024, and registered a low of $309000.0 during Q1 2021.
  • For the 5-year period, Nexgel's Cost of Revenue averaged around $972000.0, with its median value being $934500.0 (2023).
  • In the last 5 years, Nexgel's Cost of Revenue surged by 13465.91% in 2021 and then tumbled by 526.61% in 2025.
  • Over the past 5 years, Nexgel's Cost of Revenue (Quarter) stood at $429000.0 in 2021, then dropped by 2.1% to $420000.0 in 2022, then skyrocketed by 178.33% to $1.2 million in 2023, then skyrocketed by 68.26% to $2.0 million in 2024, then dropped by 14.03% to $1.7 million in 2025.
  • Its Cost of Revenue stands at $1.7 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.6 million for Q1 2025.